Sign in

CIK 0000907654 · Non-accelerated filer<br>Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
363855489
Phone
650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
  1. 4 Planned sale Senior Vice President, Finance sold 10,000 shares at an average $106.66 ($1,066,572)
  2. 4 Planned sale Chief Medical Officer sold 7,000 shares at an average $86.28 ($603,938)
  3. 4 Planned sale Senior Vice President, Finance sold 9,999 shares at an average $84.63 ($846,180)
  4. 4 Open-market sale Director sold 3,553,410 shares at $84.43 ($300,014,406)
  5. 4 Planned sale Chief Operating Officer sold 5,000 shares at an average $94.42 ($472,079)
  6. 4 Planned sale Senior Vice President, Finance sold 1,587 shares at an average $80.95 ($128,468)
  7. 4 Planned sale Senior Vice President, Finance sold 9,854 shares at an average $69.72 ($687,035)
  8. 4 Planned sale Chief Medical Officer sold 7,947 shares at an average $69.28 ($550,607)
  9. 4 Open-market sale Chief Executive Officer sold 1,729 shares at $69.69 ($120,494)
  10. 4 Open-market sale Chief Operating Officer sold 600 shares at $69.69 ($41,814)
  11. 4 Open-market sale General Counsel sold 733 shares at $69.69 ($51,083)
  12. 4 Planned sale Director sold 35,000 shares at an average $70.13 ($2,454,382)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Planned sale Director sold 105,000 shares at an average $58.97 ($6,191,366)
  19. 4 Planned sale Senior Vice President, Finance sold 10,290 shares at an average $59.07 ($607,806)
  20. 4 Planned sale Chief Medical Officer sold 7,000 shares at an average $61.85 ($432,935)

Page 2 of 23 · 458 filings